BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2022 Mainz Biomed N.V. , a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that Guido. | January 11, 2022
/PRNewswire/ Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today that.